ArticlePopulation health metrics2026
QALY losses for non-communicable diseases in Iranian adults: insights from a national cross-sectional study.
Article in Population health metrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNon-communicable diseases (NCDs), constitute a major global public health challenge and represent the primary causes of mortality and morbidity worldwide. This study aims to estimate Quality-Adjusted Life Year (QALY) losses associated with six NCDs among Iranian adults.
methodsThis study quantified QALY losses associated with six NCDs, including asthma, ischemic heart disease (IHD), stroke, hypertension, diabetes mellitus, and high cholesterol. Health-related quality of life (HRQoL) scores were derived from EQ-5D-3 L questionnaire data collected in 2021 from a nationally representative sample of 27,576 participants. Morbidity prevalence was obtained from the same survey, while mortality data were sourced from the Global Burden of Disease (GBD) study. Total QALY loss for each condition was calculated by summing losses attributable to both morbidity and mortality.
resultsWomen experienced a greater decline in HRQoL than men across all conditions. The highest disutilities were observed for stroke, IHD, and asthma in women, and for stroke, asthma, and IHD in men. The highest QALY losses were associated with hypertension (1,399,097), IHD (1,123,053), and high cholesterol (749,136). Diabetes mellitus accounted for 428,163 QALYs lost followed by Stroke (373,365) and asthma (215,498).
conclusionsGiven the substantial health burden posed by NCDs, there is an urgent need for prevention and management strategies that are both evidence-based and gender-sensitive. Strengthening national policies aimed at reducing the NCDs burden will not only enhance population health outcomes but also generate significant economic returns.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.